Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma.

被引：1
|
作者：
Hayman, Suzanne
Gertz, Morie
Lacy, Martha
Dispenzieri, Angela
Fonseca, Rafael
Geyer, Susan
Kumar, Shaji
Zeldenrust, Steven
Russell, Stephen
Lust, John
Kyle, Robert
Greipp, Philip
Witzig, Thomas
Vincent Rajkumar, S.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin Scottsdale, Scottsdale, AZ USA
[3] Mayo Clin, Rochester, MN USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3568.3568
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3568
引用
收藏
页码：1019A / 1019A
页数：1
相关论文
共 50 条
  • [1] Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma
    Detweiler-Short, Kristen
    Hayman, Suzanne
    Gertz, Morie A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Kumar, Shaji
    Zeldenrust, Steven R.
    Russell, Stephen J.
    Lust, John A.
    Kyle, Robert A.
    Greipp, Philip R.
    Witzig, Thomas E.
    Rajkumar, S. Vincent
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (10) : 737 - 740
  • [2] Single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma.
    Rajkumar, SV
    Gertz, MA
    Lacy, MQ
    Dispenzieri, A
    Fonseca, R
    Geyer, S
    Iturria, N
    Kumar, S
    Lust, JA
    Kyle, RA
    Greipp, PR
    Witzig, TE
    BLOOD, 2002, 100 (11) : 403A - 404A
  • [3] Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Smoldering or Indolent Myeloma
    Short, K. E. Detweiler
    Hayman, S. R.
    Gertz, M. A.
    Lacy, M. Q.
    Dispenzieri, A.
    Fonseca, R.
    Kumar, S.
    Zeldenrust, S. R.
    Russell, S. J.
    Lust, J. A.
    Buadi, F.
    Dingli, D.
    Kyle, R. A.
    Greipp, P. R.
    Witzig, T. E.
    Rajkumar, S. V.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S76 - S77
  • [4] Long-term results of thalidomide and dexamethasone (thal–dex) as therapy of first relapse in multiple myeloma
    Elena Zamagni
    Alessandro Petrucci
    Patrizia Tosi
    Paola Tacchetti
    Giulia Perrone
    Annamaria Brioli
    Lucia Pantani
    Beatrice Zannetti
    Carolina Terragna
    Michele Baccarani
    Michele Cavo
    Annals of Hematology, 2012, 91 : 419 - 426
  • [5] Long-term Efficacy of Single-agent Vemurafenib for Pleomorphic Xanthoastrocytoma
    Finch, Elizabeth A.
    Elton, Scott W.
    Huang, Benjamin Y.
    Trembath, Dimitri G.
    Blatt, Julie
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (02) : 152 - 155
  • [6] Long-term advanced cholangiocarcinoma survivor with single-agent capecitabine
    Petekkaya, I.
    Gezgen, G.
    Roach, E. C.
    Solak, M.
    Altundag, K.
    Gullu, I.
    JOURNAL OF BUON, 2012, 17 (04): : 796 - 796
  • [7] Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma
    Zamagni, Elena
    Petrucci, Alessandro
    Tosi, Patrizia
    Tacchetti, Paola
    Perrone, Giulia
    Brioli, Annamaria
    Pantani, Lucia
    Zannetti, Beatrice
    Terragna, Carolina
    Baccarani, Michele
    Cavo, Michele
    ANNALS OF HEMATOLOGY, 2012, 91 (03) : 419 - 426
  • [8] Long-Term Outcomes with Single-Agent BRAF-Inhibitor Therapy in Erdheim-Chester Disease
    Goyal, Gaurav
    Reiner, Anne
    Bossert, Dana
    Sigler, Allison
    Buthorn, Justin
    Lacouture, Mario
    Rotemberg, Veronica
    Francis, Jasmine H.
    Go, Ronald S.
    Rampal, Raajit K.
    Diamond, Eli L.
    BLOOD, 2023, 142
  • [9] Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response duration
    Cibeira, M. Teresa
    Rosinol, Laura
    Ramiro, Laia
    Esteve, Jordi
    Torrebadell, Montserrat
    Blade, Joan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (06) : 486 - 492
  • [10] Long-term results (10 years) of high-dose therapy in 127 patients with de novo multiple myeloma.
    Moreau, P
    Misbahi, R
    Milpied, N
    Morineau, N
    Mahé, A
    Vigier, M
    Rapp, MJ
    Bataille, R
    Harousseau, JL
    BLOOD, 2001, 98 (11) : 684A - 685A
12345